We are live on
!
Find out more
Coherus Oncology
CHRS
CHRS
157 hedge funds and large institutions have $100M invested in Coherus Oncology in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 46 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
320% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 10
37% more capital invested
Capital invested by funds: $72.8M → $100M (+$27.2M)
24% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 37
24% more funds holding
Funds holding: 127 → 157 (+30)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.91% less ownership
Funds ownership: 42.46% → 39.54% (-2.9%)
70% less call options, than puts
Call options by funds: $132K | Put options by funds: $436K
Holders
157
Holders Change
+30
Holders Change %
+23.62%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
42
Increased
46
Reduced
37
Closed
10
Calls
$132K
Puts
$436K
Net Calls
-$304K
Net Calls Change
-$804K
Top Buyers
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.49M |
| 2 |
Jane Street
New York
|
-$1,000K |
| 3 |
Millennium Management
New York
|
-$619K |
| 4 |
BlackRock
New York
|
-$351K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$286K |
